| http://www.w3.org/ns/prov#value | - Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) shares plunged 13.49 percent to $4.49 in post-market trading after the company announced that it intends to offer, subject to market and other considerations, $75 million aggregate principal amount of Convertible Senior Notes due 2019 in a private offering.
|
